CREB1 and major depressive disorder: Pde2a inhibitor had significant neuroprotective effects on depression by affecting the cGMP and cAMP signalling pathways, contain increasing the ratio of the expression of pCREB/CREB and BDNF (Liu L. et al., 2018).